Raein Katrina L, Ortiz-Hernández Samia, Benge Jared F
Department of Neurology, Division of Neuropsychology, Baylor Scott & White Health, Temple, Texas.
Plummer Movement Disorders Center, Baylor Scott & White Health, Temple, Texas.
Cogn Behav Neurol. 2019 Mar;32(1):16-24. doi: 10.1097/WNN.0000000000000184.
To report how people with Parkinson disease (pwPD) and their care partners (CPs) describe the cognitive impacts of the disease, explore the convergent validity of subjective cognitive complaints (SCCs) with measures of cognition and daily functioning, and report the cognitive treatment priorities of pwPD and their CPs.
Cognitive symptoms in pwPD are common and disabling. Although objective cognitive impairments have been closely studied, SCCs are less well understood.
Fifty dyads consisting of a person with PD and his or her CP independently completed a questionnaire that describes cognitive difficulties and was derived from a prior focus group study. Each participant rated the person with PD's degree of difficulty with symptoms and identified the top five items that would be important treatment targets. Each person with PD also completed the Montreal Cognitive Assessment (MoCA), and his or her CP completed questionnaires assessing the patient's daily functioning and the CP's distress.
Significant correlations existed between CP-reported cognitive symptoms and objective cognitive impairment as assessed by the MoCA. Both patient- and CP-reported SCCs were correlated with the pwPD's cognition as assessed by the MoCA, with an increasing number of SCCs reported with declining cognition. In general, the pwPD self-reported more SCCs than did the CPs, but for patients with dementia, the CPs reported more SCCs. Language and decision-making were the top treatment priorities.
In view of the array of cognitive impacts of PD, clinicians and researchers must consider both the reporter (patient or CP) and the overall stage of a patient's cognitive decline when evaluating SCCs.
报告帕金森病患者(pwPD)及其照护伙伴(CPs)如何描述该疾病的认知影响,探讨主观认知主诉(SCCs)与认知及日常功能测量指标的收敛效度,并报告pwPD及其CPs的认知治疗优先事项。
pwPD的认知症状常见且会导致功能障碍。尽管客观认知障碍已得到深入研究,但SCCs的了解较少。
由50对PD患者及其CP组成的小组独立完成一份描述认知困难的问卷,该问卷源自先前的焦点小组研究。每位参与者对PD患者症状的困难程度进行评分,并确定作为重要治疗目标的前五项内容。每位PD患者还完成了蒙特利尔认知评估(MoCA),其CP完成了评估患者日常功能和CP痛苦程度的问卷。
CP报告的认知症状与MoCA评估的客观认知障碍之间存在显著相关性。患者和CP报告的SCCs均与MoCA评估的pwPD认知相关,认知能力下降时报告的SCCs数量增加。总体而言,pwPD自我报告的SCCs比CPs多,但对于痴呆患者,CPs报告的SCCs更多。语言和决策是首要治疗重点。
鉴于PD的一系列认知影响,临床医生和研究人员在评估SCCs时必须考虑报告者(患者或CP)以及患者认知衰退的整体阶段。